USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Novozymes Biologicals Limited

USPTO PatentsView assignee record - 21 granted patents across 13 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators).

RSS updates for this company

The verdict

According to USPTO PatentsView, Novozymes ranks #14,177 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 13 technology areas.

#14,177
of 49,997 US assignees by volume
48th percentile
by Innovation Score (34.7/100)
16.6
avg claims per patent
-76%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14177 · Foreign Corporation #14,177 · 21 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 21 grants
  • MID-PACK #14,177/49,997
  • PHOTO-FINISH Namiki Seimitsu…
  • CPC-FOCUS A01N · 13 areas
  • INNOV-THIN 34.7/100
  • CLAIMS-RICH 16.6 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -76% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Namiki Seimitsu Houseki Kabushiki Kaisha (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Novozymes

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Novozymes's Innovation Score is 34.7/100 (48th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Novozymes's grants concentrate

Novozymes Biologicals Limited is a focused PatentsView assignee: 13 CPC subclasses with 57.1% of grants classified under A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2020. By volume, Novozymes sits between Nisshinbo Chemical Inc. and Neptun Light, Inc..

Novozymes's three-year grant acceleration

Novozymes Biologicals Limited shows 1 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Novozymes's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Novozymes holds 21 patents at rank #14,166, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Novozymes

By rank, the assignees closest to #14,166 in granted patent volume.

Leaders in A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR…)

Other assignees with the most granted patents in Novozymes's primary technology class.

Novozymes's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 48th percentile higher than 48% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 20152016201720182019202020212024 1
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Novozymes Biologicals Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 14.3%
2016 5 23.8%
2017 3 14.3%
2018 4 19.0%
2019 2 9.5%
2020 1 4.8%
2021 2 9.5%
2024 1 4.8%

Which technologies does Novozymes Biologicals Limited patent most?

Top 13 of 13 technology areas

Where it ranks

Overall rank by patents

#14,177

of 49,997 tracked assignees

Innovation Score

34.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Novozymes Biologicals Limited's patent record in context - here's where to go next.

  • Novozymes Biologicals Limited's lead technology class is A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators), 57.1% of its portfolio - see every assignee active in that class. Explore A01N
  • Ranked #14,177 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Novozymes Biologicals Limited against Nisshinbo Chemical Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 34.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.